SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-015079
Filing Date
2007-03-01
Accepted
2007-02-28 19:12:31
Documents
15
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-1942_110k.htm 10-K 2094716
2 EX-4.1 a07-1942_1ex4d1.htm EX-4.1 58695
3 EX-10.5 a07-1942_1ex10d5.htm EX-10.5 55851
4 EX-10.32 a07-1942_1ex10d32.htm EX-10.32 10833
5 EX-10.38 a07-1942_1ex10d38.htm EX-10.38 171073
6 EX-23.1 a07-1942_1ex23d1.htm EX-23.1 4029
7 EX-31.1 a07-1942_1ex31d1.htm EX-31.1 12749
8 EX-31.2 a07-1942_1ex31d2.htm EX-31.2 14703
9 EX-32 a07-1942_1ex32.htm EX-32 15599
10 GRAPHIC g19422mai001.gif GRAPHIC 949
11 GRAPHIC g19422mai002.gif GRAPHIC 429
12 GRAPHIC g19422mai003.gif GRAPHIC 1032
13 GRAPHIC g19422mai004.gif GRAPHIC 521
14 GRAPHIC g19421dei001.gif GRAPHIC 21928
15 GRAPHIC g19421dmi001.gif GRAPHIC 15333
  Complete submission text file 0001104659-07-015079.txt   2496001
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 07659925
SIC: 2834 Pharmaceutical Preparations